IHT Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

IHT Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-9	Closed	-$1K	–	909
2018 Q1	$1K	Sell	9 -150	-94%	-$22K	﹤0.01%	1598
2017 Q4	$22K	Sell	159 -175	-52%	-$24.3K	0.01%	960
2017 Q3	$49K	Buy	334 +69	+26%	+$10.4K	0.02%	526
2017 Q2	$8K	Sell	265 -50	-16%	-$7.65K	﹤0.01%	1015
2017 Q1	$44K	Sell	315 -120	-28%	-$15.6K	0.03%	448
2016 Q4	$48K	Buy	+435	New	+$48.5K	0.04%	398

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

IHT Wealth Management's JAZZ Position: Q2 2018 in Review

IHT Wealth Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2018, closing a stake of 9 shares — an estimated $1K sold.

IHT Wealth Management first reported a position in JAZZ in Q4 2016 and held it in 6 quarters. The position peaked at $49K in Q3 2017. 376 funds tracked by Wall St. Rank hold JAZZ as of Q2 2018.

IHT Wealth Management reported no remaining Jazz Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
IHT Wealth Management sold 9 Jazz Pharmaceuticals shares in Q2 2018, an estimated $1K.
IHT Wealth Management first reported a position in Jazz Pharmaceuticals in Q4 2016 and held it in 6 quarters.
IHT Wealth Management's Jazz Pharmaceuticals position peaked at $49K in Q3 2017.
376 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2018.

Based on IHT Wealth Management's 13F filing for Q2 2018, filed 13 Aug 2018.